We are here! GLIIFCA (Great Lakes International Imaging and Flow Cytometry Association) meeting at the Marriott Cincinnati Rivercenter. Stop by the ThinkCyte table to meet Greg Schneider and learn more about VisionSort and the power of morphological profiling and AI in flow cytometry. Greg will also be giving a talk this evening entitled, "Label –free Morphological Cell Profiling and Sorting by Ghost Cytometry." Add a new dimension to your cellular analysis and sorting workflows in: Cell Therapy R&D, Drug Discovery Screening and Disease Profiling https://hubs.li/Q02PSfbS0 #labelfree #flowcytometry #AI GLIIFCA #cellsorting #cellprofiling
ThinkCyte’s Post
More Relevant Posts
-
There's still time to connect with Shivali Joshi about her poster presentation on CAR-T cell therapy AD platforms and characterization at the Cell Therapy Analytical Development Summit. Request a meeting to dive deeper into analytical insights that drive successful cell-based therapies forward. https://lnkd.in/g9y852jX #celltherapyanalyticaldevelopment #cellandgenetherapy #cdmo #CARTanalytics #CART #advancedtherapies #celltherapies #celltherapymanufacturing #cellandgenetherapymanufacturing #advancedtherapymanufaturing #CMC #CARTmanufacturing #cgtforwardprogress
-
✨ Register Now! ✨ Join us for TOMORROW'S webinar providing a thorough analysis of Champions' revolutionary TumorGraft3D platform, a proprietary ex vivo multiclonal 3D organ-like tumor culture assay derived from our industry-leading clinically relevant patient-derived xenograft (PDX) models. Attend this webinar to: ✔ Gain comprehensive insights into the TumorGraft3D platform and its robust capabilities ✔ Discover specific readouts including cytotoxicity, flow cytometry, high-content imaging, DRUGseq, and luciferase-tagged models for superior research outcomes ✔ Understand the applications of the platform to refine your preclinical programs Register to attend live or on-demand: https://hubs.li/Q02tNHNT0 #organoid #3Dcultures #exvivo #PDXmodels #3D #oncologyresearch #preclinical #flowcytometry #HCI #DRUGseq
-
-
Research: Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-analysis. https://lnkd.in/ebZ3kruz
-
-
Customer Engaging, Technical Sales Special who bridges the gaps from challenge to solution!!!
Super powerful and completely flexible.
Understand the Life of Single-Cells with Bruker Cellular Analysis's Beacon® Platform! Our cutting-edge technology is revolutionizing the way researchers conduct live single-cell multiomics, paving the way for breakthroughs in antibody discovery, cell line development, T cell profiling, and CAR/TCR therapy.
-
Business Development Senior Manager, Western Southern Europe at Champions Oncology, Inc
Register now and join the webinar today at 6 pm CET (or watch the record later on) to learn more on Champions' ex vivo TumorGraft3D platform:
✨ Register Now! ✨ Join us for TOMORROW'S webinar providing a thorough analysis of Champions' revolutionary TumorGraft3D platform, a proprietary ex vivo multiclonal 3D organ-like tumor culture assay derived from our industry-leading clinically relevant patient-derived xenograft (PDX) models. Attend this webinar to: ✔ Gain comprehensive insights into the TumorGraft3D platform and its robust capabilities ✔ Discover specific readouts including cytotoxicity, flow cytometry, high-content imaging, DRUGseq, and luciferase-tagged models for superior research outcomes ✔ Understand the applications of the platform to refine your preclinical programs Register to attend live or on-demand: https://hubs.li/Q02tNHNT0 #organoid #3Dcultures #exvivo #PDXmodels #3D #oncologyresearch #preclinical #flowcytometry #HCI #DRUGseq
-
-
Join us for an upcoming webinar that provides thorough analysis of Champions' revolutionary TumorGraft3D platform, a proprietary ex vivo multiclonal 3D organ-like tumor culture assay derived from our industry-leading clinically relevant patient-derived xenograft (PDX) models. Attend this webinar to: ✔ Gain comprehensive insights into the TumorGraft3D platform and its robust capabilities ✔ Discover specific readouts including cytotoxicity, flow cytometry, high-content imaging, DRUGseq, and luciferase-tagged models for superior research outcomes ✔ Understand the applications of the platform to refine your preclinical programs Register to attend live or on-demand: https://hubs.li/Q02sC1-J0 #organoid #3Dcultures #exvivo #PDXmodels #3D #oncologyresearch #preclinical #flowcytometry #HCI #DRUGseq
-
-
BLOG ALERT: Cell-based assays sit at the core of cell therapy research and development and are crucial for ensuring the safety and efficacy of new treatments. However, the success of these assays heavily relies on the viability of cell samples, which can be compromised by conventional separation techniques. Our latest blog highlights how Levitation Technology™ is revolutionizing sample preparation, ensuring higher cell viability and boosting the accuracy and reliability of assays. Discover how levitation innovation is transforming cell therapy R&D for safer, more effective treatments. Dive into the full story here: https://bit.ly/3UFbETL #CellTherapyResearch #LevitationTechnology #SamplePreparation
-
-
The latest blog highlights show you how Levitation Technology™ is revolutionizing sample preparation, ensuring higher cell viability and boosting the accuracy and reliability of assays. Read the blog from LevitasBio to learn more! #Blog #Revolution #Cells #Explore #CellTherapy #Research
BLOG ALERT: Cell-based assays sit at the core of cell therapy research and development and are crucial for ensuring the safety and efficacy of new treatments. However, the success of these assays heavily relies on the viability of cell samples, which can be compromised by conventional separation techniques. Our latest blog highlights how Levitation Technology™ is revolutionizing sample preparation, ensuring higher cell viability and boosting the accuracy and reliability of assays. Discover how levitation innovation is transforming cell therapy R&D for safer, more effective treatments. Dive into the full story here: https://bit.ly/3UFbETL #CellTherapyResearch #LevitationTechnology #SamplePreparation
-
-
Great to see CRB's continued leadership and input into the ISPE baseline guides, especially for our #ATMP community. ISPE's ATMP Allogeneic Cell Therapy Guide is here, and our team at CRB is proud of Niranjan Kulkarni for co-authoring the Supply Chain chapter! This Guide is a robust resource with input from several industry experts focusing primarily on allogeneic cell therapies, specifically manufacturing facility development and design. It also outlines common challenges with allogeneic cell therapy facilities, design concepts specific to allogeneic cell therapy facilities, and GMP layout and architectural design development. Learn more about the guide at the link below. #LifeSciences #ATMP #SupplyChain #CellTherapy
CRB’s Niranjan Kulkarni contributes to ISPE’s ATMP Allogeneic Cell Therapy Baseline Guide
share.postbeyond.com
-
The power and flexibility of #Beacon in 3D animation! Take a journey as if you are a single cell: First discovering an unparalleled breadth of data on your functional abilities, then being recovered alive to either scale up into a breakthrough therapeutic or getting sequenced to connect your genotype to your phenotype! #thepowerofbeacon Bruker Cellular Analysis
Understand the Life of Single-Cells with Bruker Cellular Analysis's Beacon® Platform! Our cutting-edge technology is revolutionizing the way researchers conduct live single-cell multiomics, paving the way for breakthroughs in antibody discovery, cell line development, T cell profiling, and CAR/TCR therapy.
